![Roberto Saviane](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roberto Saviane
Director/Board Member at Pitagora SpA
Profile
Roberto Saviane is currently a Director at Pitagora SpA.
Previously, he was the Chairman at DeA Capital Alternative Funds SGR SpA from 2011 to 2020.
He was also a Partner at Wise Equity SGR SpA from 2004 to 2016.
Additionally, he held positions as a Director at Finanziaria Canova SpA and OphthalmoPharma AG.
Roberto Saviane active positions
Companies | Position | Start |
---|---|---|
Pitagora SpA
![]() Pitagora SpA Finance/Rental/LeasingFinance Pitagora SpA provides financing and consumer credit services. It offers business and salary loans. The company was founded by Massimo Sanson in 1995 and is headquartered in Turin, Italy. | Director/Board Member | 2010-03-18 |
Former positions of Roberto Saviane
Companies | Position | End |
---|---|---|
Dea Capital Alternative Funds SGR SpA
![]() Dea Capital Alternative Funds SGR SpA Investment ManagersFinance DeA Capital Alternative Funds SGR SpA (Dea Capital Alternative Funds) is a private equity subsidiary of DeA Capital SpA (Private Equity) founded in 2000. The firm is headquartered in Milan, Italy. | Chairman | 2020-04-19 |
OphthalmoPharma AG
![]() OphthalmoPharma AG Medical SpecialtiesHealth Technology OphthalmoPharma AG develops ophthalmology treatments. Its product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration. The company's product include EyeBar, a nutraceutical for the prevention of dry age-related macular degeneration and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery. OphthalmoPharma was founded by Sebastien Putallaz and Gamil G. de Chadarevian in 2003 and is headquartered in Sarnen, Switzerland. | Director/Board Member | - |
Wise Equity SGR SpA
![]() Wise Equity SGR SpA Investment ManagersFinance Wise Equity SGR SpA (Wise equity) is a private equity firm founded in 2000 by Paolo Gambarini and Michele Semenzato. The firm is headquartered in Milan, Italy. | Director/Board Member | - |
Finanziaria Canova SpA
![]() Finanziaria Canova SpA Financial ConglomeratesFinance Finanziaria Canova SpA operates as a holding company. It provides administrative, business planning and consulting services. The company was founded in September 2001 and is headquartered in Milan, Italy. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Finanziaria Canova SpA
![]() Finanziaria Canova SpA Financial ConglomeratesFinance Finanziaria Canova SpA operates as a holding company. It provides administrative, business planning and consulting services. The company was founded in September 2001 and is headquartered in Milan, Italy. | Finance |
Wise Equity SGR SpA
![]() Wise Equity SGR SpA Investment ManagersFinance Wise Equity SGR SpA (Wise equity) is a private equity firm founded in 2000 by Paolo Gambarini and Michele Semenzato. The firm is headquartered in Milan, Italy. | Finance |
Pitagora SpA
![]() Pitagora SpA Finance/Rental/LeasingFinance Pitagora SpA provides financing and consumer credit services. It offers business and salary loans. The company was founded by Massimo Sanson in 1995 and is headquartered in Turin, Italy. | Finance |
Dea Capital Alternative Funds SGR SpA
![]() Dea Capital Alternative Funds SGR SpA Investment ManagersFinance DeA Capital Alternative Funds SGR SpA (Dea Capital Alternative Funds) is a private equity subsidiary of DeA Capital SpA (Private Equity) founded in 2000. The firm is headquartered in Milan, Italy. | Finance |
OphthalmoPharma AG
![]() OphthalmoPharma AG Medical SpecialtiesHealth Technology OphthalmoPharma AG develops ophthalmology treatments. Its product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration. The company's product include EyeBar, a nutraceutical for the prevention of dry age-related macular degeneration and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery. OphthalmoPharma was founded by Sebastien Putallaz and Gamil G. de Chadarevian in 2003 and is headquartered in Sarnen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Roberto Saviane